Neuropharmacology and Psychoactive Drugs

Neurotransmitter System Overview

  • The neurotransmitter system maintains alertness and wakefulness in the brain.
    • Ranges from awake-alert to varying degrees of sleep (including coma and death).
    • Important for understanding the effects of certain drugs.

Alcohol and Its Effects

  • Alcohol impacts the brain stem, particularly the reticular activating system (RAS).
    • The RAS regulates the awake vs. alert state of the brain.
  • Initial feeling of sleepiness when consuming alcohol.

Cholinergic and Dopaminergic Systems

  • Loss of cholinergic neurons is associated with Alzheimer's disease.
  • The dopaminergic system consists of two pathways:
    • Motor Pathway: Facilitates movement.
    • Reward Pathway: Associated with feelings of pleasure and reinforcement (related to drug abuse).
    • Drug abuse can activate both pathways, leading to symptoms similar to Parkinson's disease.

Overview of Major Neurotransmitter Systems

  • Noradrenergic System:
    • Not a major focus of this course, relates to memory formation and learning (neuroplasticity).
    • Important for studying and improving memory—"cells that fire together wire together."
  • Role of Noradrenaline:
    • Essential for structural changes in the brain during learning.
  • Implications for Antidepressants:
    • SSRIs (Selective Serotonin Reuptake Inhibitors) target serotonin but won't help those with low noradrenaline.
    • Need to consider selective noradrenaline reuptake inhibitors for effective treatment.

Understanding Psychiatric Conditions

  • Conditions such as depression, anxiety, bipolar disorder, and ADHD:
    • Can be caused by imbalances in serotonin, noradrenaline, or dopamine.
    • Treatment approaches must consider the specific neurotransmitter system involved.
    • For bipolar disorder, drug treatments seek to stabilize mood between depression and mania.

Serotonergic System

  • Plays a role in sleep-wake cycles and is involved when the brain is moving.
  • Movement activates RAS, refreshing alertness (important for studying).
  • Issues with serotonin levels can lead to:
    • Depression
    • Sleep disorders (e.g., sleep apnea)
    • Sudden Infant Death Syndrome (SIDS): Research connects SIDS to serotonergic dysfunction, leading to failure to reactivate breathing during sleep.

Ethical Considerations and Current Research

  • Debate surrounding the therapeutic potential of psychedelics like ketamine for treatment-resistant depression.
  • Questions of legalization and potential benefits vs. risks.

Transition to Topic on Drugs

  • Introduction to drugs from a psychopharmacological perspective.
    • Focus on psychoactive drugs that alter behavior, cognition, or mood.
  • Legal vs. illegal drug debates, with historical context on substances such as cannabis and psychedelics.

Defining Drugs and Routes of Administration

  • Drug Definition:
    • Any chemical that produces a change in the body.
  • Oral Administration:
    • Common and generally safe, but not the most effective way to take drugs (first pass metabolism reduces efficacy).
    • Discusses barriers for drugs entering the bloodstream and challenges of different routes.

Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion (ADME)

  • ADME Details:
    • Absorption: How a drug enters the body.
    • Distribution: How it spreads through the body (influenced by route of administration).
    • Metabolism: Primarily in the liver, involves breaking drugs down with enzymes (e.g., cytochrome P450).
    • Excretion: Removing drugs from the body (mostly via kidneys, but can also involve sweat, tears, etc.).

First-Pass Metabolism

  • Refers to metabolism of drugs during their first pass through the liver, which can diminish their bioavailability.
  • Importance of understanding first-pass effects when considering oral administration and overall drug efficacy.

Blood-Brain Barrier (BBB)

  • BBB is a protective barrier that restricts most substances from entering the brain, allowing only certain chemicals to pass (glucose, oxygen).
    • Certain psychoactive substances including alcohol and nicotine can cross the BBB.
  • Structure of BBB:
    • Composed of tightly packed cells, preventing toxins from entering the brain.
  • Active Transport Mechanisms:
    • Larger or charged drugs may require specific transport proteins to enter the brain.

Drug Design and Structure Mimicry

  • For a drug to effectively cross the BBB, it must be:
    1. A small molecule
    2. Uncharged (neither positively nor negatively)
    3. Fat-soluble (to pass through lipid membranes).
  • Substances that do not meet these criteria may need to hijack transport mechanisms to cross the BBB.

Metabolism of Drugs

  • Drugs are metabolized in the liver, where enzymatic breakdown takes place.
  • Prodrugs:
    • Substances that have no psychoactive effect until metabolized into an active form (e.g., psilocybin from mushrooms).
  • Interactions Between Drugs:
    • Co-consumption of alcohol and cocaine can yield a more potent psychoactive metabolite.

Excretion of Drugs

  • Drugs are typically excreted through urine, but can also be expelled through breaths (breathalyzers measure metabolized alcohol).
  • Different drugs follow different elimination pathways that can impact detection in drug testing.

Pharmacokinetic Profile of Drugs

  • Drugs generally follow first-order kinetics, except for substances like alcohol, which follow zero-order kinetics (elimination rate constant regardless of concentration in the bloodstream).
    • Important for understanding the effects of alcohol consumption and hangover prevention myths.

Summary: The course encapsulates neuropharmacology, the interplay of neurotransmitter systems, implications for psychiatric disorders, and foundational principles of drug pharmacokinetics.